Pharmazz - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2010, Pharmazz operates in Health Tech offering novel products in critical care medicine. The company has developed Centhaquine for hypovolemic shock and Sovateltide for cerebral ischemic s...
Funding stage:
Corporate Round
Last funding:
22/05/2025
Total funding:
$45.82 Mn+
Investors
Employee count:
42
Last 90d
42
Last 90d
Web traffic:
1.39K
1.39K
Last 30d
Last 30d
Glassdoor Rating:
Pharmazz: Funding Highlights
Funding highlights of Pharmazz and a snapshot of its key metrics.
Total Funding$45.82 Mn+
Current StageUndisclosed
Total Round(s)5
Funding Rounds
FAQs on Funding of Pharmazz
Health Tech Funded Pharmazz has raised a total funding of $45.82 million as of 23 May 2025 across 5 rounds. Find the details around funding rounds, participating investors, and other insights of Pharmazz here...
Pharmazz has raised a total of $45.82 million across 5 funding rounds and the last round was raised on 23 May 2025.
Pharmazz's key investors include Sun Pharmaceutical Industries.
Pharmazz's latest funding round was $25.00 million in Undisclosed, raised on 23 May 2025.
Pharmazz is at the Undisclosed stage. Its most recent round was raised on 23 May 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links